OPKO Health Corp. (OPK): Growth-Adjusted Market Cap to Net Income

Geopolitical tensions are hindering reagent supplies and disrupting OPKO Health, Inc. (OPK) contracts across several countries. A stable moat is based on patents and laboratory capacities, although maintaining these positions is costly. The GURU.Markets portal features a chart where the PEG ratio trajectory demonstrates that the metric level is 0.00. The holding's diversified format successfully protects capital from the risks of slow approvals for new drugs.

OPKO Corp (OPK): Price/Earnings to Growth Ratio from 07/04/2022 to 11/12/2026

Metric breakdowns and analytics for OPKO Health, Inc. (OPK)

- current quotes and average value forecast:

Market Price OPKO Health Inc|OPK - Price Target Chart

- stock exchange capitalization data:

Market Capitalization OPKO Corp|OPK - Enterprise Value

- company book value details:

Net Assets per Share OPKO Health|OPK - Company Book Value|Market Capitalization to Book Value opko.com|OPK - Aggregate Company Assets

- debt obligations and liquidity statistics:

- net income and valuation ratios data:

OPK - Net Profit|Expected Net Income OPKO Health, Inc.|OPK - P/E Multiple|Projected Price to Earnings Ratio OPKO Health Corp.|OPK - PEG Multiple|EV/EBITDA Multiple OPKO Corp|OPK - Profit before payment of interest, taxes and amortization|Earnings per share for the last twelve months OPKO Health|OPK - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months opko.com|OPK - Earnings growth in current year|Expected earnings per share trend next year OPKO Health, Inc.

Fundamental company analysis:OPK OPKO Health Inc

Mass-produced product of OPKO Health Corp.

Stable capital flows from laboratory diagnostics and pharmaceuticals at OPKO Health, Inc. (OPK) create a solid foundation for business scaling. The PEG ratio compares the stock's market value with earnings growth, allowing for the identification of undervalued assets via the average PEG value; meanwhile, values below one signal growth potential that an investor must weigh against historical price volatility.

Competitors of OPKO Health, Inc.